Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Brain Behav Immun. 2018 Mar 20;70:354–368. doi: 10.1016/j.bbi.2018.03.025

Table 3.

Comparison of PBMC cytokine production after 24 hours of stimulation with TLR-4 agonist between ASDNOGI, ASDGI and TDNOGI. Data presented as median and interquartile ranges.

TLR4 (LPS)
ASDNOGI Median
(IQR)
ASDGI Median
(IQR)
TDNOGI Median
(IQR)
IL-1α 3,959‡*
(3,615-4,376)
3,160
(1,602-4,036)
2,660
(1,115-3,913)
IL-1β 12,506
(9,304-17,562)
10,727
(7,888-15,632)
9,782
(6,370-12,298)
IL-6 35,049
(26,923-46,236)
33,143
(20,277-41,781)
31,468
(21,858-47,848)
IL-12p40 43.69
(19.39-75.11)
39.28
(19.39-96.25)
57.64
(36.21-75.11)
IL-12p70 5.35
(3.34-7.46)
7.46
(3.588-9.65)
7.63
(5.35-9.65)
TNFα 4,072
(2,904-5,139)
4,084
(2,765-5,959)
3,071
(2,074-3,989)
IFNγ 159.90
(53.63-293.20)
253.50
(85.24-878)
168.90
(75.51-288.20)
IL-4 2.25
(2.25-4.16)
2.25
(2.25-11.13)
2.25
(2.25-11.13)
IL-13 19.50
(13.48-28.99)
20.80
(15.14-30.88)
19.50
(14.16-24.65)
IL-10 9,253
(4,421-10,885)
6,151
(3,007-10,047)
6,048
(3,904-8,017)
TGFβ 1,981
(1,043-3,899)
1,179#
(820.70-2,010)
2,590
(1,261-4,745)
IL-5 1.36*
(0.25-3.39)
3.39#
(2.61-6.35)
2.43
(1.62-3.05)
IL-15 19.50
(13.48-28.99)
20.80
(15.14-30.88)
19.50
(14.16-24.65)
IL-17 0.35*
(0.35-0.35)
0.48#
(0.35-3.24)
3.28
(1.00-6.145)
*

p value < 0.05 when comparing ASD GI with ASD no GI

#

p value < 0.05 when comparing ASD GI with TD

p value < 0.05 when comparing ASD no GI with TD

HHS Vulnerability Disclosure